nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE8B—leg—bone cancer	0.103	0.226	CbGeAlD
Flavoxate—PDE8B—forelimb—bone cancer	0.103	0.225	CbGeAlD
Flavoxate—PDE8B—hindlimb—bone cancer	0.0923	0.202	CbGeAlD
Flavoxate—PDE8B—appendage—bone cancer	0.0792	0.173	CbGeAlD
Flavoxate—Antrafenine—PTGS2—bone cancer	0.0208	0.612	CrCbGaD
Flavoxate—PDE7B—tendon—bone cancer	0.0195	0.0427	CbGeAlD
Flavoxate—PDE8A—tendon—bone cancer	0.014	0.0306	CbGeAlD
Flavoxate—PDE8A—spinal cord—bone cancer	0.0135	0.0295	CbGeAlD
Flavoxate—Raloxifene—CYP3A4—bone cancer	0.0132	0.388	CrCbGaD
Flavoxate—PDE4D—tendon—bone cancer	0.0127	0.0277	CbGeAlD
Flavoxate—PDE4B—tendon—bone cancer	0.00668	0.0146	CbGeAlD
Flavoxate—PDE4B—bone marrow—bone cancer	0.00647	0.0142	CbGeAlD
Flavoxate—PDE4B—spinal cord—bone cancer	0.00644	0.0141	CbGeAlD
Flavoxate—PDE7B—Signaling by GPCR—GNA11—bone cancer	0.00187	0.00366	CbGpPWpGaD
Flavoxate—PDE7B—GPCR downstream signaling—IL3—bone cancer	0.00186	0.00366	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—GRM4—bone cancer	0.00185	0.00362	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—RGS1—bone cancer	0.00185	0.00362	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—GRM4—bone cancer	0.00183	0.0036	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—RGS1—bone cancer	0.00183	0.0036	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—RGS1—bone cancer	0.00176	0.00346	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—GRM4—bone cancer	0.00176	0.00346	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—GRM1—bone cancer	0.00175	0.00344	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—GNA11—bone cancer	0.00173	0.00341	CbGpPWpGaD
Flavoxate—PDE7A—GPCR downstream signaling—IL3—bone cancer	0.00173	0.0034	CbGpPWpGaD
Flavoxate—CHRM1—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.00173	0.00339	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—GRM1—bone cancer	0.00171	0.00336	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—RGS1—bone cancer	0.00171	0.00335	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—GRM4—bone cancer	0.00171	0.00335	CbGpPWpGaD
Flavoxate—CHRM2—Calcium Regulation in the Cardiac Cell—GNA11—bone cancer	0.0017	0.00334	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—IL3—bone cancer	0.00169	0.00332	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—GRM1—bone cancer	0.00168	0.0033	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—GRM4—bone cancer	0.00168	0.00329	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—RGS1—bone cancer	0.00168	0.00329	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—GRM1—bone cancer	0.0016	0.00314	CbGpPWpGaD
Flavoxate—PDE4D—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.0016	0.00314	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—GRM1—bone cancer	0.00159	0.00312	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—IL3—bone cancer	0.00157	0.00309	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—RGS1—bone cancer	0.00155	0.00305	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—GRM4—bone cancer	0.00155	0.00305	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—GRM1—bone cancer	0.00153	0.003	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—GRM1—bone cancer	0.00148	0.00291	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—GRM1—bone cancer	0.00145	0.00285	CbGpPWpGaD
Flavoxate—CHRM1—G alpha (q) signalling events—GNA11—bone cancer	0.00144	0.00282	CbGpPWpGaD
Flavoxate—PDE4B—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.00141	0.00277	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—GNA11—bone cancer	0.00136	0.00267	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—SMO—bone cancer	0.00135	0.00265	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—SMO—bone cancer	0.00135	0.00265	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—EZH2—bone cancer	0.00135	0.00265	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—GRM1—bone cancer	0.00135	0.00264	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—GRM4—bone cancer	0.0013	0.00255	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.00129	0.00253	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—GRM4—bone cancer	0.00128	0.00252	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—GNA11—bone cancer	0.00125	0.00244	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—GNA11—bone cancer	0.00124	0.00243	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—GNA11—bone cancer	0.00124	0.00243	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—SMO—bone cancer	0.00124	0.00243	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—SMO—bone cancer	0.00121	0.00237	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—RGS1—bone cancer	0.0012	0.00235	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—GRM4—bone cancer	0.0012	0.00235	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—ATF1—bone cancer	0.00115	0.00226	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—ATF1—bone cancer	0.00115	0.00226	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—GNA11—bone cancer	0.00113	0.00222	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—IL3—bone cancer	0.00113	0.00222	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—GRM1—bone cancer	0.00113	0.00221	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL3—bone cancer	0.00112	0.0022	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL3—bone cancer	0.00112	0.0022	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—SMO—bone cancer	0.00112	0.0022	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—GRM1—bone cancer	0.00111	0.00218	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—GNA11—bone cancer	0.0011	0.00216	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—GNA11—bone cancer	0.00108	0.00213	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—SMO—bone cancer	0.00108	0.00211	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RGS1—bone cancer	0.00104	0.00204	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GRM4—bone cancer	0.00104	0.00204	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—GRM1—bone cancer	0.00104	0.00203	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—GNA11—bone cancer	0.00103	0.00203	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL3—bone cancer	0.00103	0.00201	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—GNA11—bone cancer	0.00102	0.00201	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—ATF1—bone cancer	0.00102	0.00201	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—SMO—bone cancer	0.00102	0.00201	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL3—bone cancer	0.000999	0.00196	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GRM4—bone cancer	0.000991	0.00194	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RGS1—bone cancer	0.000991	0.00194	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—GNA11—bone cancer	0.000984	0.00193	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—IL3—bone cancer	0.000983	0.00193	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TGFBR2—bone cancer	0.000959	0.00188	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TGFBR2—bone cancer	0.000959	0.00188	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—GNA11—bone cancer	0.000955	0.00187	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—ATF1—bone cancer	0.000953	0.00187	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—SMO—bone cancer	0.000948	0.00186	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—GNA11—bone cancer	0.000937	0.00184	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—IL3—bone cancer	0.000935	0.00184	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL3—bone cancer	0.000929	0.00182	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GRM4—bone cancer	0.000917	0.0018	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RGS1—bone cancer	0.000917	0.0018	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GRM1—bone cancer	0.000902	0.00177	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IGF1R—bone cancer	0.000902	0.00177	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IGF1R—bone cancer	0.000902	0.00177	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL3—bone cancer	0.000892	0.00175	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—GNA11—bone cancer	0.000867	0.0017	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—IL3—bone cancer	0.000865	0.0017	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GRM1—bone cancer	0.000859	0.00169	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—BRAF—bone cancer	0.000858	0.00168	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TGFBR2—bone cancer	0.000855	0.00168	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL3—bone cancer	0.000849	0.00167	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—BRAF—bone cancer	0.000847	0.00166	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IGF1R—bone cancer	0.000804	0.00158	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TGFBR2—bone cancer	0.000795	0.00156	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GRM1—bone cancer	0.000795	0.00156	CbGpPWpGaD
Flavoxate—CHRM1—GPCR ligand binding—SMO—bone cancer	0.000793	0.00156	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL3—bone cancer	0.000786	0.00154	CbGpPWpGaD
Flavoxate—CHRM2—GPCR ligand binding—SMO—bone cancer	0.000783	0.00154	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—CDK4—bone cancer	0.000763	0.0015	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IGF1R—bone cancer	0.000748	0.00147	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—RGS1—bone cancer	0.000734	0.00144	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GRM4—bone cancer	0.000734	0.00144	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—SMO—bone cancer	0.00073	0.00143	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—RGS1—bone cancer	0.000724	0.00142	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GRM4—bone cancer	0.000724	0.00142	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—GNA11—bone cancer	0.000668	0.00131	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—RGS1—bone cancer	0.000666	0.00131	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GRM4—bone cancer	0.000666	0.00131	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—RGS1—bone cancer	0.000658	0.00129	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GRM4—bone cancer	0.000658	0.00129	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—KIT—bone cancer	0.000654	0.00128	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—KIT—bone cancer	0.000654	0.00128	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GRM1—bone cancer	0.000636	0.00125	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SMO—bone cancer	0.000636	0.00125	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GRM1—bone cancer	0.000628	0.00123	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—ATF1—bone cancer	0.000621	0.00122	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—BRAF—bone cancer	0.000615	0.00121	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—BRAF—bone cancer	0.000615	0.00121	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL3—bone cancer	0.000606	0.00119	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SMO—bone cancer	0.000605	0.00119	CbGpPWpGaD
Flavoxate—PDE8A—Signaling by GPCR—EGFR—bone cancer	0.000596	0.00117	CbGpPWpGaD
Flavoxate—PDE8B—Signaling by GPCR—EGFR—bone cancer	0.000596	0.00117	CbGpPWpGaD
Flavoxate—CHRM2—SIDS Susceptibility Pathways—JUN—bone cancer	0.000595	0.00117	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—KIT—bone cancer	0.000583	0.00114	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—GNA11—bone cancer	0.000581	0.00114	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GRM1—bone cancer	0.000578	0.00113	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GRM1—bone cancer	0.00057	0.00112	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SMO—bone cancer	0.00056	0.0011	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—GNA11—bone cancer	0.000553	0.00109	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—BRAF—bone cancer	0.000548	0.00108	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—KIT—bone cancer	0.000542	0.00106	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—ATF1—bone cancer	0.000541	0.00106	CbGpPWpGaD
Flavoxate—PDE7B—Signaling by GPCR—EGFR—bone cancer	0.000531	0.00104	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL3—bone cancer	0.000527	0.00103	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFBR2—bone cancer	0.000518	0.00102	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MDM2—bone cancer	0.000515	0.00101	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MDM2—bone cancer	0.000515	0.00101	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—ATF1—bone cancer	0.000515	0.00101	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—GNA11—bone cancer	0.000512	0.00101	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—BRAF—bone cancer	0.00051	0.001	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL3—bone cancer	0.000502	0.000985	CbGpPWpGaD
Flavoxate—PDE7A—Signaling by GPCR—EGFR—bone cancer	0.000494	0.00097	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—JUN—bone cancer	0.000492	0.000965	CbGpPWpGaD
Flavoxate—CHRM1—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000491	0.000964	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IGF1R—bone cancer	0.000487	0.000956	CbGpPWpGaD
Flavoxate—CHRM2—Regulation of Actin Cytoskeleton—EGFR—bone cancer	0.000485	0.000952	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—ATF1—bone cancer	0.000476	0.000935	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL3—bone cancer	0.000464	0.000911	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MDM2—bone cancer	0.000459	0.000902	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFBR2—bone cancer	0.000451	0.000885	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—JUN—bone cancer	0.000448	0.000879	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—JUN—bone cancer	0.000448	0.000879	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—MMP9—bone cancer	0.000436	0.000856	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—MMP9—bone cancer	0.000436	0.000856	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFBR2—bone cancer	0.000429	0.000842	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MDM2—bone cancer	0.000427	0.000838	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IGF1R—bone cancer	0.000424	0.000833	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—GNA11—bone cancer	0.00041	0.000805	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—SMO—bone cancer	0.000407	0.000799	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—GNA11—bone cancer	0.000405	0.000794	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IGF1R—bone cancer	0.000404	0.000793	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—SMO—bone cancer	0.000402	0.000789	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—JUN—bone cancer	0.000399	0.000784	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFBR2—bone cancer	0.000397	0.000779	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GRM4—bone cancer	0.000394	0.000773	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RGS1—bone cancer	0.000394	0.000773	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GRM4—bone cancer	0.000389	0.000763	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RGS1—bone cancer	0.000389	0.000763	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—MMP9—bone cancer	0.000388	0.000763	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IGF1R—bone cancer	0.000374	0.000733	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—GNA11—bone cancer	0.000372	0.000731	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL3—bone cancer	0.000372	0.00073	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—JUN—bone cancer	0.000371	0.000729	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—GNA11—bone cancer	0.000368	0.000721	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL3—bone cancer	0.000367	0.00072	CbGpPWpGaD
Flavoxate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000366	0.000719	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—MMP9—bone cancer	0.000361	0.000709	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—KIT—bone cancer	0.000353	0.000694	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—EGFR—bone cancer	0.000352	0.000691	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—EGFR—bone cancer	0.000352	0.000691	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GRM1—bone cancer	0.000341	0.00067	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL3—bone cancer	0.000338	0.000663	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GRM1—bone cancer	0.000337	0.000661	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL3—bone cancer	0.000333	0.000654	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—BRAF—bone cancer	0.000332	0.000652	CbGpPWpGaD
Flavoxate—CHRM1—Circadian rythm related genes—TP53—bone cancer	0.000325	0.000637	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—EGFR—bone cancer	0.000322	0.000632	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—EGFR—bone cancer	0.000314	0.000616	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KIT—bone cancer	0.000308	0.000604	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—TP53—bone cancer	0.000296	0.00058	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—TP53—bone cancer	0.000296	0.00058	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KIT—bone cancer	0.000293	0.000575	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—EGFR—bone cancer	0.000292	0.000573	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—BRAF—bone cancer	0.000289	0.000568	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—EGFR—bone cancer	0.00028	0.00055	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MDM2—bone cancer	0.000278	0.000546	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—BRAF—bone cancer	0.000275	0.00054	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KIT—bone cancer	0.000271	0.000532	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—EGFR—bone cancer	0.000267	0.000524	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—bone cancer	0.000264	0.000517	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—BRAF—bone cancer	0.000255	0.0005	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—EGFR—bone cancer	0.000247	0.000485	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—bone cancer	0.000245	0.000481	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MDM2—bone cancer	0.000242	0.000476	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—JUN—bone cancer	0.000242	0.000475	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SMO—bone cancer	0.00024	0.000472	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SMO—bone cancer	0.000237	0.000466	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MMP9—bone cancer	0.000235	0.000462	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MDM2—bone cancer	0.000231	0.000453	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNA11—bone cancer	0.00022	0.000432	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNA11—bone cancer	0.000217	0.000426	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MDM2—bone cancer	0.000213	0.000419	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—JUN—bone cancer	0.000211	0.000413	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MMP9—bone cancer	0.000205	0.000402	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ATF1—bone cancer	0.000204	0.000401	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ATF1—bone cancer	0.000202	0.000396	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—JUN—bone cancer	0.0002	0.000393	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL3—bone cancer	0.000199	0.000391	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL3—bone cancer	0.000197	0.000386	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MMP9—bone cancer	0.000195	0.000383	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—bone cancer	0.00019	0.000373	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—JUN—bone cancer	0.000185	0.000364	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MMP9—bone cancer	0.00018	0.000354	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFBR2—bone cancer	0.000171	0.000335	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFBR2—bone cancer	0.000168	0.00033	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—bone cancer	0.000166	0.000325	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1R—bone cancer	0.00016	0.000315	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—bone cancer	0.00016	0.000313	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1R—bone cancer	0.000158	0.000311	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—bone cancer	0.000158	0.000309	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—bone cancer	0.000146	0.000286	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—bone cancer	0.000139	0.000273	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—bone cancer	0.000132	0.00026	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—bone cancer	0.000122	0.00024	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KIT—bone cancer	0.000116	0.000228	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KIT—bone cancer	0.000115	0.000225	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BRAF—bone cancer	0.000109	0.000215	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BRAF—bone cancer	0.000108	0.000212	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—bone cancer	0.000106	0.000208	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—bone cancer	0.000105	0.000205	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MDM2—bone cancer	9.16e-05	0.00018	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MDM2—bone cancer	9.05e-05	0.000178	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—JUN—bone cancer	7.97e-05	0.000156	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—JUN—bone cancer	7.86e-05	0.000154	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP9—bone cancer	7.75e-05	0.000152	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP9—bone cancer	7.65e-05	0.00015	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—bone cancer	6.26e-05	0.000123	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—bone cancer	6.18e-05	0.000121	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—bone cancer	5.26e-05	0.000103	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—bone cancer	5.19e-05	0.000102	CbGpPWpGaD
